Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Manu Vatish, Professor of Obstetrics & Consultant Obstetrician who has been appointed as the new Deputy Director for Maternal and Child Health Discovery at the Bill & Melinda Gates Foundation.

The goal of the MaternalNewborn & Child Health Discovery & Tools team at the Bill & Melinda Gates Foundation is to ensure that women and newborns remain healthy before, during, and after childbirth, including by supporting the development, testing, and scale-up of innovative solutions to address underlying vulnerabilities contributing to poor health.

Congratulations to Manu Vatish, Professor of Obstetrics & Consultant Obstetrician who has been appointed as the new Deputy Director for Maternal and Child Health Discovery at the Bill & Melinda Gates Foundation. He will take up this role while continuing his role as Professor of Obstetrics in the Nuffield Department of Women's & Reproductive Health (NDWRH) at the University of Oxford.

The goal of the Maternal, Newborn & Child Health Discovery & Tools team at the Bill & Melinda Gates Foundation is to ensure that women and newborns remain healthy before, during, and after childbirth, including by supporting the development, testing, and scale-up of innovative solutions to address underlying vulnerabilities contributing to poor health.

Professor Manu Vatish has worked in NDWRH for the past 10 years. In addition to his University role, he is Honorary Consultant at the John Radcliffe Hospital in Oxford, part of the Oxford University Hospitals NHS Trust. He has also been Clinical Director for the National Institutes for Health and Care Research (NIHR) Clinical Research Network in the Thames Valley and South Midlands, and sits on the NIHR National Reproductive Health & Childbirth committee. He is a Royal College of Obstetricians and Gynaecologists College Tutor for Oxford, and has been Academic Training Programme Director for the Clinical Graduate School at Oxford. His clinical and research interests are in high-risk pregnancy, with a special focus on preeclampsia - a pregnancy-related condition with substantial associated global morbidity and mortality. He has led research on angiogenic biomarkers in this disease as well as in the basic science underlying this condition, and has been involved in several high impact clinical trials which have changed clinical practice. Together with Emeritus Professor Chris Redman, his group is also working on the expansion and improvement of the Dawes-Redman Cardiotocography CTG system for the antenatal detection of pregnancy complications.

 

Manu VatishUpon taking up this exciting new role at the Bill & Melinda Gates Foundation, Professor Vatish commented "I am delighted to be joining the amazing team at the Bill and Melinda Gates Foundation to help deliver the very best healthcare for women and their babies. I look forward to engaging with the teams in Seattle and London and am excited by the opportunities this role offers to make a real difference to healthcare for women and children around the world."

 

 

 

Krina ZondervanProfessor Krina Zondervan, Head of NDWRH commented: ‘Huge congratulations to Professor Vatish on this important global appointment, which is testimony to his significant achievements in maternal health research. I know he will fulfil his new role with passion and dedication, the Foundation are fortunate to have him!’.

Similar stories

Maternal fat metabolism in pregnancy and fetal abdominal growth influence child weight

A new study, led by researchers at the Nuffield Department of Women's & Reproductive Health, University of Oxford, in collaboration with the University of California, Berkeley, USA, published in The Lancet Diabetes & Endocrinology identifies, as early as the 5th month of pregnancy, patterns of fetal abdominal growth associated with maternal lipid metabolites that track newborn growth, adiposity and development into childhood.

New Professor of Obstetrics Title

Enormous well done to our new Professor Sally Collins - she was conferred the title of Professor of Obstetrics by the University's Medical Sciences Division Board.

INTERCOVID Study cited in the New Yorker

Fantastic news for our team who have been working on the INTERCOVID Study, which launched in April 2020. This week on 12th August 2022, the research findings cited in the New Yorker! This work was a combined effort from 43 institutions in 18 countries and involved more than two thousand pregnant women.

Women's Health Strategy for England Launched

The government has published the first ever Women's Health Strategy for England to tackle the gender health gap. Menopause, Endometriosis, Contraception and Fertility treatment are highlighted as some of the top issues women have asked for action on. The Nuffield Department of Women's & Reproductive Health welcome and fully support this bold and exciting strategy to help improve the health of millions of women in England.

Pregnancy is more likely with urine tests and timed intercourse

Dr Tatjana Gibbons leads study that suggests a woman's chance of conceiving is improved by using urine tests to detect the optimum time for intercourse, but further research is still needed to assess whether timed intercourse via any ovulation detection method creates a difference in live births and pregnancy rates.

Dawes-Redman Education awarded funds from Huntleigh Healthcare

The Dawes-Redman Education programme which offers virtual CTG Analysis training sessions to Obstetric consultants, antenatal and student midwives has received generous funds from Huntleigh Healthcare for the next 3 years.